Search research articles
Contact Us
Filters
Showing results (311-320 of 342) with videos related to
Page
of 35
Sort By:
BMC Cancer
|
December 16, 2017
Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society
Christoph Kowalski, Ullrich Graeven, Christof von Kalle, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 22, 2020
Initial experience with [<sup>18</sup>F]DPA-714 TSPO-PET to image inflammation in primary angiitis of the central nervous system
Philipp Backhaus, Wolfgang Roll, Carolin Beuker, et al.
Genome Medicine
|
September 24, 2022
Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma
Michael Heming, Svea Haessner, Jolien Wolbert, et al.
Brain & Spine
|
September 23, 2024
Fluorescence guidance in skull base surgery: Applications and limitations - A systematic review
Eric Suero Molina, Michael Bruneau, Gilles Reuter, et al.
Cancers
|
September 10, 2021
Impact of Adjuvant Radiotherapy in Patients with Central Neurocytoma: A Multicentric International Analysis
Laith Samhouri, Mohamed A M Meheissen, Ahmad K H Ibrahimi, et al.
Brain : a Journal of Neurology
|
September 30, 2019
Human CCR5high effector memory cells perform CNS parenchymal immune surveillance via GZMK-mediated transendothelial diapedesis
Sebastian Herich, Tilman Schneider-Hohendorf, Astrid Rohlmann, et al.
Acta Neurochirurgica
|
September 25, 2014
Predicting the "usefulness" of 5-ALA-derived tumor fluorescence for fluorescence-guided resections in pediatric brain tumors: a European survey
Walter Stummer, Floriano Rodrigues, Philippe Schucht, et al.
The Lancet. Oncology
|
September 7, 2019
Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial
Johannes Weller, Theophilos Tzaridis, Frederic Mack, et al.
Cancer Research
|
October 28, 2025
Integrated Single-Nucleus and Spatial Transcriptomics Elucidate Heterogeneity and Hypoxia-Driven Organization of Supratentorial Ependymoma
Erik Schüftan, I-Na Lu, Flavia W de Faria, et al.
Journal of Neuro-Oncology
|
September 20, 2023
Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses
Thomas Zeyen, Daniel Paech, Johannes Weller, et al.
Page
of 35
Search research articles
Search
Showing results (311-320 of 342) with videos related to
Sort By:
Page
of 35
BMC Cancer
|
December 16, 2017
Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society
Christoph Kowalski, Ullrich Graeven, Christof von Kalle, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 22, 2020
Initial experience with [<sup>18</sup>F]DPA-714 TSPO-PET to image inflammation in primary angiitis of the central nervous system
Philipp Backhaus, Wolfgang Roll, Carolin Beuker, et al.
Genome Medicine
|
September 24, 2022
Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma
Michael Heming, Svea Haessner, Jolien Wolbert, et al.
Brain & Spine
|
September 23, 2024
Fluorescence guidance in skull base surgery: Applications and limitations - A systematic review
Eric Suero Molina, Michael Bruneau, Gilles Reuter, et al.
Cancers
|
September 10, 2021
Impact of Adjuvant Radiotherapy in Patients with Central Neurocytoma: A Multicentric International Analysis
Laith Samhouri, Mohamed A M Meheissen, Ahmad K H Ibrahimi, et al.
Brain : a Journal of Neurology
|
September 30, 2019
Human CCR5high effector memory cells perform CNS parenchymal immune surveillance via GZMK-mediated transendothelial diapedesis
Sebastian Herich, Tilman Schneider-Hohendorf, Astrid Rohlmann, et al.
Acta Neurochirurgica
|
September 25, 2014
Predicting the "usefulness" of 5-ALA-derived tumor fluorescence for fluorescence-guided resections in pediatric brain tumors: a European survey
Walter Stummer, Floriano Rodrigues, Philippe Schucht, et al.
The Lancet. Oncology
|
September 7, 2019
Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial
Johannes Weller, Theophilos Tzaridis, Frederic Mack, et al.
Cancer Research
|
October 28, 2025
Integrated Single-Nucleus and Spatial Transcriptomics Elucidate Heterogeneity and Hypoxia-Driven Organization of Supratentorial Ependymoma
Erik Schüftan, I-Na Lu, Flavia W de Faria, et al.
Journal of Neuro-Oncology
|
September 20, 2023
Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses
Thomas Zeyen, Daniel Paech, Johannes Weller, et al.
Page
of 35